Preclinical graft study supports Cytori’s proposed mechanism of action

[News]

Cytori Therapeutics reported results from a preclinical cell-enriched fat grafting study supporting the safety and efficacy of Cytori’s method for enriching fat grafts with adipose-derived regenerative cells (ADRCs).

More... (http://www.news-medical.net/news/20091214/Preclinical-graft-study-supports-Cytorie28099s-proposed-mechanism-of-action.aspx)